VANCOUVER, British Columbia, March 22, 2022 (GLOBE NEWSWIRE) — Telecure Technologies Inc. (CSE: TELE) (FSE: 6MZ) (the “Company” or “Telecure”) is pleased to report the results of its Annual General Meeting (“the Meeting”) of shareholders held today in Vancouver. All resolutions proposed in the management information circular for the Meeting were passed by shareholders.
Shareholders set the number of directors to hold office for the ensuing year at five, and supported each of the nominees – Harwinder Parmar, Joshua Rosenberg, Faizaan Lalani, Aman Parmar and Paul More – nominated by management for election as a director of the Company.
|Votes For||% Votes For||Votes Withheld||% Votes Withheld|
Shareholders also supported the re-appointment of GreenGrowth CPAs to serve as the auditor of the Company for the ensuing year at a remuneration to be determined by the Board of Directors.
A total of 62,126,739 common shares representing 73.68% of the outstanding common shares were represented in person or by proxy at the meeting.
Further details on the matters considered at the meeting can be found in Telecure’s 2021 Management Information Circular, which is available under the Company’s profile on SEDAR.
About Telecure Technologies Inc.
Telecure is a U.S. focused health IT company that specializes in using technology to make healthcare more accessible and efficient. Telecure offers customized solutions for telemedicine needs. Through an acquisition strategy and unique customization capabilities, Telecure is focused on advancing its patient and user base. The Company provides a complete telemedicine solution via its platforms CallingDr™ and FindingDr™.
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business and future of the Company’s business and plans. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported.
The Canadian Securities Exchange (CSE) has not reviewed, approved or disapproved the contents of this news release.